The vagus nerve is the body’s longest cranial nerve, running from the brainstem to the abdomen and touching nearly every major organ along the way. It governs heart rate, digestion, breathing, immune responses, and mood — and when it stops working properly, the effects can ripple across every system simultaneously. Lifestyle techniques such as breathing exercises and meditation can support vagal tone in healthy people, but true vagus nerve dysfunction — whether from surgical trauma, neurological disease, or chronic illness — often requires clinical evaluation and targeted medical treatment.
The good news is that the field has advanced significantly in recent years. New FDA approvals, non-invasive stimulation devices, and a deeper understanding of the vagus nerve’s role in inflammation and the gut-brain axis are giving patients and clinicians more options than ever. This guide covers the signs that warrant professional attention, the diagnostic tools physicians use, and the full range of medical therapies now available to restore vagus nerve function.
Signs of Vagus Nerve Dysfunction
Because the vagus nerve innervates the heart, lungs, throat, and entire gastrointestinal tract, dysfunction can present in many ways. Symptoms tend to cluster by organ system.
Cardiovascular
Inappropriate drops in heart rate (bradycardia), episodes of fainting or near-fainting (vasovagal syncope), and reduced heart rate variability are hallmark signs. Some patients experience postural orthostatic tachycardia syndrome (POTS), in which heart rate spikes abnormally on standing. Blood pressure instability — particularly sudden drops during meals or changes in position — can also point to vagal involvement, since the nerve helps coordinate the baroreceptor reflex that keeps blood pressure steady.
Gastrointestinal
The vagus nerve drives stomach motility, enzyme secretion, and the migrating motor complex that keeps digestion moving between meals. Damage can cause gastroparesis — delayed stomach emptying that produces nausea, bloating, early fullness, and vomiting. Chronic constipation, acid reflux, and irritable bowel symptoms may also reflect impaired vagal signaling.
Respiratory and Laryngeal
The vagus nerve controls the muscles of the larynx. Injury — often during thyroid or carotid surgery — can cause vocal cord paresis, leading to hoarseness, a weak or breathy voice, difficulty swallowing (dysphagia), and an impaired cough reflex.
Neuropsychiatric
Vagal tone influences the release of neurotransmitters including serotonin, GABA, and norepinephrine. Persistently low vagal tone is associated with treatment-resistant depression, heightened anxiety, poor stress recovery, and, in some cases, drug-resistant epilepsy.
Immune and Inflammatory
The vagus nerve operates the cholinergic anti-inflammatory pathway, a reflex arc that keeps systemic inflammation in check. When this pathway is impaired, chronic low-grade inflammation can contribute to autoimmune flares, particularly in conditions like rheumatoid arthritis and inflammatory bowel disease.
Diagnosing Vagus Nerve Disorders
No single test captures the full picture. Physicians typically combine clinical history with targeted investigations depending on which organ system is affected.
Heart rate variability (HRV) analysis is the most accessible measure of vagal tone. A consistently low HRV on ambulatory monitoring suggests reduced parasympathetic drive. HRV is increasingly used not only for diagnosis but also to track response to treatment over time.
Gastric emptying studies — usually a scintigraphy scan in which patients eat a radiolabeled meal — are the standard diagnostic for gastroparesis. A wireless motility capsule that measures pressure, pH, and transit time as it travels the GI tract can provide additional detail.
Laryngeal electromyography (EMG) evaluates the electrical activity of vocal cord muscles and can distinguish between nerve injury and mechanical causes of hoarseness. Flexible laryngoscopy allows direct visualization of vocal cord movement.
Electroencephalography (EEG) and brain imaging help map seizure activity in epilepsy patients being evaluated for vagus nerve stimulation therapy.
Autonomic function testing provides a broader view. Tilt-table tests assess how the cardiovascular system responds to positional changes, revealing vasovagal syncope or POTS. Quantitative sudomotor axon reflex testing (QSART) measures sweat gland function as a proxy for small-fibre autonomic nerve health. Together, these tests can distinguish vagal-specific dysfunction from more generalised autonomic neuropathy.
A newer diagnostic concept gaining traction is cervicovagopathy, a framework proposed in 2025 that categorises vagus nerve disorders by the location and mechanism of nerve injury — structural compression, inflammatory damage, post-surgical trauma, or functional dysregulation — rather than by the downstream symptoms alone. This approach may help clinicians identify patients who would benefit most from vagus-nerve-targeted treatments.
Your local vagus nerve experts
Find a vagus nerve practitioner near you
Our directory lists 2,685 practitioners across the US, from polyvagal-informed therapists to HRV biofeedback clinics.
Or browse by approach
- Polyvagal-informed therapy
- Somatic therapy
- HRV biofeedback
- Craniosacral therapy
- Breathwork
- Insomnia therapy (CBT-I)
The directory covers the United States for now. Listings come from practitioners’ own websites and are not endorsements or medical advice. Browse the full directory.
Medical Treatments for Vagus Nerve Healing
Implanted Vagus Nerve Stimulation (VNS)
Surgically implanted VNS devices deliver regular electrical pulses to the left cervical vagus nerve via a small pulse generator placed under the skin of the chest. This approach has the longest clinical track record and the broadest range of approved indications.
Epilepsy: VNS has been FDA-approved for drug-resistant epilepsy since 1997. It does not eliminate seizures for most patients, but studies show it reduces seizure frequency by 50% or more in roughly half of recipients, with efficacy often improving over the first two years of use.
Depression: VNS received FDA approval for treatment-resistant depression in 2005. It is typically considered after multiple medication trials and psychotherapy have failed. Response rates in long-term follow-up studies range from 30% to 50%.
Stroke rehabilitation: In 2021 the FDA approved paired VNS — short bursts of stimulation timed to coincide with rehabilitation movements — for chronic ischemic stroke. Clinical trials demonstrated significant improvements in upper limb motor function when VNS was combined with intensive physical therapy. A 2025 systematic review confirmed that paired VNS can improve motor outcomes after stroke, and a Cochrane review the same year found emerging (though still limited) evidence supporting this approach. Ongoing research is extending the technique to traumatic brain injury and spinal cord injury rehabilitation.
Rheumatoid arthritis: In a landmark 2025 decision, the FDA approved a bioelectronic VNS device developed by SetPoint Medical for rheumatoid arthritis — the first approval targeting the cholinergic anti-inflammatory pathway. The RESET-RA trial showed that stimulating the vagus nerve could reduce joint inflammation in patients who had not responded adequately to biologic drugs, marking a milestone for the field of bioelectronic medicine.
Side effects of implanted VNS are generally mild and tend to diminish over time. The most common include hoarseness or voice changes during stimulation, coughing, throat tingling, and mild shortness of breath. Serious complications such as infection at the implant site are rare. The procedure itself is typically outpatient, performed under general anaesthesia, with most patients returning to normal activity within a week.
Transcutaneous Auricular VNS (taVNS)
Non-invasive taVNS delivers electrical stimulation through the skin of the ear — typically the cymba conchae or tragus — targeting the auricular branch of the vagus nerve. It requires no surgery, and several commercial devices are now available for home use.
The evidence base for taVNS is expanding rapidly. A 2025 meta-analysis published in Neuromodulation found that taVNS significantly relieved insomnia symptoms. Randomised trials published in 2025 and 2026 show promising results for depression, generalised anxiety disorder, and post-stroke motor recovery. A 2025 Frontiers review characterised taVNS as a multifaceted approach to stroke rehabilitation, citing evidence for benefits across motor, sensory, neuropsychiatric, and cognitive domains.
Typical clinical protocols involve 30-minute sessions, often twice daily, at stimulation frequencies between 20 and 25 Hz. A 2025 review in Neural Regeneration Research emphasised the importance of optimising stimulation parameters — including frequency, intensity, and timing relative to rehabilitation exercises — to maximise therapeutic benefit.
Medications
No drug directly repairs the vagus nerve, but several medications address specific consequences of dysfunction. Prokinetic agents such as metoclopramide and domperidone can improve gastric emptying in gastroparesis. Antiemetics manage nausea. For cardiac symptoms, beta-blockers or other rate-control medications may be necessary. In epilepsy, VNS is used alongside (not instead of) anti-seizure medications. GLP-1 receptor agonists, originally developed for diabetes, are now being studied for their vagally mediated effects on appetite, metabolism, and even neuroprotection.
Emerging Therapies
Closed-Loop VNS
Conventional VNS devices deliver stimulation on a fixed schedule regardless of what the body needs at any given moment. Closed-loop systems aim to change that by adjusting stimulation in real time based on physiological biomarkers — heart rate, EEG patterns, or inflammatory markers. A 2026 study from Xuanwu Hospital demonstrated the feasibility of adaptive vagus nerve stimulation that responds to seizure-related brain activity, delivering pulses only when needed. This approach could reduce side effects while improving efficacy, and similar adaptive systems are under development for depression and cardiac applications.
Bioelectronic Medicine
The 2025 RA approval opened the door to a broader vision: using targeted nerve stimulation to treat inflammatory and autoimmune diseases that currently rely on immunosuppressive drugs. Researchers are now investigating vagus nerve stimulation for inflammatory bowel disease, Crohn’s disease, lupus, and type 2 diabetes. The underlying principle — that the nervous system can be used to regulate immune function as precisely as a drug — represents a fundamental shift in how chronic disease may be managed. Unlike pharmaceutical immunosuppression, which dampens the immune system broadly and increases infection risk, bioelectronic approaches work through the body’s own anti-inflammatory reflex, potentially offering a more targeted and reversible form of immune modulation.
Gut-Brain Axis Therapies
Research published in 2025 from UCLA provided the first direct causal evidence that specific gut microbial metabolites activate vagal neurons, confirming the vagus nerve’s role as the primary communication channel in the gut-brain axis. A 2026 study in Cell Stem Cell showed that sleep deprivation sends aberrant signals through the vagus nerve that can damage intestinal stem cells — and that blocking those signals protects the gut. These findings are driving interest in targeted probiotics and dietary interventions that modulate vagal function from below, though clinical applications remain early-stage.
Supporting Recovery
Medical treatment works best alongside lifestyle measures that support overall vagal tone. Regular aerobic exercise — even moderate-intensity walking or swimming — has been shown to improve heart rate variability, a reliable proxy for vagal health. HRV biofeedback, a technique in which patients learn to synchronise their breathing with their heart rhythm using a real-time monitor, has shown promise for insomnia, anxiety, and cardiovascular regulation in multiple 2025 clinical studies. Consistent sleep habits, stress management through breathwork or meditation, and an anti-inflammatory diet rich in omega-3 fatty acids, fibre, and fermented foods further support the gut-brain axis. For a detailed guide to natural vagus nerve support techniques, see our companion article on how to naturally heal the vagus nerve.
When to See a Doctor
Seek medical evaluation if you experience unexplained gastroparesis symptoms (persistent nausea, vomiting, early satiety), recurrent fainting or near-fainting episodes, new-onset hoarseness or swallowing difficulty (especially after neck or chest surgery), seizures that do not respond to medication, or depression that has not improved after multiple treatment attempts. A neurologist, gastroenterologist, or electrophysiologist can determine whether vagus nerve dysfunction is contributing to your symptoms and whether targeted therapies such as VNS are appropriate. Early referral matters — for conditions like post-stroke motor impairment, pairing VNS with rehabilitation as early as possible may improve long-term outcomes.
Want to understand how your vagus nerve shapes your health from head to gut? The “My Vagus Nerve & Me” eBook covers the science of vagal function, practical stimulation techniques, and the latest clinical developments in one accessible guide. Get My Vagus Nerve & Me eBook and take the next step toward informed, evidence-based care of your vagus nerve.
